Elsevier Science Inc.

SHERPA: Unknown

People

  1. Lewis
    Lewis
  2. Pillarsetty
    Pillarsetty
  3. Blasberg
    Blasberg
  4. Cheung
    Cheung
  5. Humm
    Humm
  6. Zeglis
    Zeglis
  7. Bilsky
    Bilsky
  8. Zanzonico
    Zanzonico
  9. Guo
    Guo
  10. Ling
    Ling

Groups

  1. Radiology, Department of (87)
  2. GSK Faculty (76)
  3. Radiochemistry and Imaging Sciences Service (56)
  4. Center for Pancreatic Cancer Research (37)
  5. Sloan Kettering Institute Faculty (37)
  6. Molecular Pharmacology and Chemistry Program Faculty (36)
  7. Sloan Kettering Institute Postdocs (36)
  8. Molecular Imaging and Therapy Service (35)
  9. Center for Molecular Imaging and Biotechnology (25)
  10. Center for Molecular Imaging and Biotechnology (CMIB) (21)
Search Within
  1. "Radiology, Department of"
Formats
  1. Journal Article (60)
  2. Meeting Abstract (23)
  3. Review (2)
  4. Conference Paper (1)
  5. Editorial (1)
Groups
  1. Radiology, Department of (87)
  2. GSK Faculty (76)
  3. Radiochemistry and Imaging Sciences Service (56)
  4. Center for Pancreatic Cancer Research (37)
  5. Sloan Kettering Institute Faculty (37)
  6. Molecular Pharmacology and Chemistry Program Faculty (36)

More Groups

People
  1. Jason Lewis (35)
  2. Steven Larson (27)
  3. Nagavarakishore Pillarsetty (13)
  4. Ronald Finn (11)
  5. Ronald Blasberg (8)
  6. Andrew Scott (7)

More People

Years
  1. 2025 (1)
  2. 2024 (2)
  3. 2023 (7)
  4. 2022 (10)
  5. 2021 (5)
  6. 2020 (4)

More Years

Publications
  1. Nuclear Medicine and Biology (69)
  2. NeoPlasia (12)
  3. Spine Journal (5)
  4. Revista Espanola de Medicina Nuclear (1)

Results (87)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • (89)Z-immuno-PET guided preclinical development of targeted therapies: Demonstrating utility by evaluating fusion proteins in vivo
    Meeting Abstract

    Herrero Alvarez, N.; Lewis, J.; Molvi, Z.; O'Reilly, R.; Nyakatura, E.; Balderes, P.; Viray, T.
    Nuclear Medicine and Biology (2022)

    Fulltext@MSK | Save
  • Investigating different chelators for a pretargeting approach with (203:212)Pb- and (64:67)Cu-labeled tetrazines
    Meeting Abstract

    Bauer, D.; Michel, A.; Kaminsky, S.; Li, M. S.; Schultz, M.; Saini, S.; Lapi, S.; Lewis, J.
    Nuclear Medicine and Biology (2022)

    Fulltext@MSK | Save
  • (177)Lu and (227)Th Labeled 3,4,3-(LI-1,2-HOPO): Characterization, optimized synthesis, biological distribution and dosimetry
    Meeting Abstract

    Sanders, V.; Phipps, M.; Demoin, D.; Pratt, E.; Bhupathiraju, N. V. S. D.; Ponnala, S.; Ferdous, J.; Schlyer, D.; Carter, L.; Lewis, J.; more...
    Nuclear Medicine and Biology (2022)

    Fulltext@MSK | Save
  • Synthesis and evaluation of a bivalent radiohapten for DOTA-based pretargeted radioimmunotherapy
    Meeting Abstract

    Veach, D.; Vaughn, B.; Vargas, D. B.; Seo, S.; Punzalan, B.; Xu, H.; Guo, H. F.; Krebs, S.; Yang, G.; Ouerfelli, O.; more...
    Nuclear Medicine and Biology (2022)

    Fulltext@MSK | Save
  • Preclinical development of [(89)Zr]Zr-DFO-Isatuximab as a novel immunoPET tracer for CD38-targeted imaging of multiple myeloma and lymphomas
    Meeting Abstract

    Herrero Alvarez, N.; Lewis, J.
    Nuclear Medicine and Biology (2022)

    Fulltext@MSK | Save
  • Evaluation of 3,4,3-LI(1,2-HOPO) as a chelator for radioscandium based radiopharmaceuticals
    Meeting Abstract

    Phipps, M.; Cingoranelli, S.; Lewis, J.; Lapi, S.; Cutler, C.; Francesconi, L.; Deri, M.
    Nuclear Medicine and Biology (2022)

    Fulltext@MSK | Save
  • Cholesterol-depleting drugs for HER2-targeted radioimmunotherapy of patient-derived esophagogastric (EG) cancer
    Meeting Abstract

    Rao, Y.; Pereira, P.; Samuels, Z.; Lewis, J.
    Nuclear Medicine and Biology (2022)

    Fulltext@MSK | Save
  • Detecting EGFR expression in bladder cancer using [(89)Zr]Zr-DFO-Panitumumab immunoPET imaging
    Meeting Abstract

    Hoang, T.; Mandleywala, K.; Tan, K.; Pereira, P.; Lewis, J.
    Nuclear Medicine and Biology (2022)

    Fulltext@MSK | Save
  • Investigating the theranostic potential of a novel MUC16-targeted antibody for ovarian cancer
    Meeting Abstract

    Mack, K.; Mandleywala, K.; Samuels, Z.; Brooks, C.; Radhakrishnan, P.; Hollingsworth, M.; Lewis, J.
    Nuclear Medicine and Biology (2022)

    Fulltext@MSK | Save
  • (111)In/(225)Ac theranostic pretargeting of nodular colorectal peritoneal carcinomatosis: Preclinical SPECT and autoradiography studies
    Meeting Abstract

    Chung, S.; Chandler, C.; Veach, D.; McDevitt, M.; Zanzonico, P.; Seo, S.; Punzalan, B.; Burnes Vargas, D.; Xu, H.; Guo, H. F.; more...
    Nuclear Medicine and Biology (2022)

    Fulltext@MSK | Save

    • Elsevier Science Inc. – authorized name for: